Gastric Cancer
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 15, 2004; 10(6): 776-782
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.776
Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas
Jun-Qiang Chen, Wen-Hua Zhan, Yu-Long He, Jun-Sheng Peng, Jian-Ping Wang, Shi-Rong Cai, Jin-Ping Ma
Jun-Qiang Chen, Wen-Hua Zhan, Yu-Long He, Jun-Sheng Peng, Jian-Ping Wang, Shi-Rong Cai, Jin-Ping Ma, Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
Author contributions: All authors contributed equally to the work.
Supported by the National Natural Science Foundation of China, No. 30271276
Correspondence to: Dr. Wen-Hua Zhan, Department of Gastrointestinal Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China. wzwk@gzsums.edu.cn
Telephone: +86-20-87755766 Ext 8211 Fax: +86-20-87335945
Received: November 17, 2003
Revised: November 23, 2003
Accepted: December 16, 2003
Published online: March 15, 2004
Abstract

AIM: To explore the expression of heparanase gene, CD44v6, MMP-7 and nm23 proteins in human gastric carcinoma as well as their relationship with the clinicopathological factors.

METHODS: Reverse transcription polymerase chain reaction (RT-PCR) was used to measure the expressions of heparanase mRNA in 43 human gastric carcinomas and 10 adjacent normal gastric tissues. Streptavidin-peroxidase (S-P) two step method was used to measure the immunohistochemical expression of CD44v6, MMP-7 and nm23 protein in 43 human gastric carcinomas.

RESULTS: The expression of heparanase gene was positive in 29 cases of gastric cancer with a positive rate of 67.4%, which was significantly higher than those in adjacent normal gastric tissues (P < 0.05). The heparanase mRNA expression was significantly related to advanced stage of disease, serosal infiltration, lymph node metastasis and size of tumors (P < 0.05), but not related to tumor location, gross and histological types of the cancer, peritoneal dissemination and liver metastasis (P > 0.05). The positive rate of CD44v6, nm23 and MMP-7 proteins was 76.7%, 37.2% and 60.5%, respectively. The CD44v6 protein expression was significantly related to serosal infiltration, lymph node metastasis and TNM stage of disease (P < 0.05). The nm23 protein expression was significantly related to the tumor gross appearance, lymph node and peritoneal metastasis (P < 0.05). The MMP-7 protein expression was significantly related to serosal infiltration and TNM stage of disease (P < 0.05). In an attempt to measure the association between these agents, we found that the expression of heparanase mRNA had significantly negative correlation with the expression of CD44v6 and MMP-7 protein (P < 0.05), the expression of MMP-7 protein had significantly positive correlation with the expression of CD44v6 protein (r = 0.568, P < 0.05), the expression of MMP-7 protein had no correlation with the expression of nm23 protein (P > 0.05), and the expression of nm23 protein had no correlation with the expression of CD44v6 protein (P > 0.05).

CONCLUSION: Despite their different mechanisms of action, heparanase, CD44v6 and nm23 may play important roles in the invasive infiltration and lymph node metastasis in gastric carcinomas. Instead of metastatic spreading, MMP-7 may be just related to the invasion of gastric carcinomas. However, co-detection of these factors may be important to predict metastatic spreading in such patients.

Keywords: $[Keywords]